Lavipharm (Greece) Today

LAVI Stock  EUR 0.89  0.01  1.14%   

Performance

6 of 100

 
Low
 
High
Modest

Odds Of Distress

Over 66

 
100  
 
Zero
Quite High
Lavipharm is selling for under 0.89 as of the 28th of March 2024; that is 1.14% increase since the beginning of the trading day. The stock's last reported lowest price was 0.87. Lavipharm has more than 66 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Lavipharm SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of April 2022 and ending today, the 28th of March 2024. Click here to learn more.
Lavipharm S.A. develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products in Greece and internationally. Lavipharm S.A. was founded in 1911 and is based in Paiania, Greece. LAVIPHARM operates under Drug Manufacturers - Major classification in Greece and is traded on Athens Stock Exchange.. The company has 18.29 M outstanding shares. More on Lavipharm SA

Moving together with Lavipharm Stock

  0.86TPEIR Piraeus FinancialPairCorr
  0.73ETE National BankPairCorr
  0.73EUROB Eurobank ErgasiasPairCorr
  0.81ELPE Hellenic PetroleumPairCorr

Moving against Lavipharm Stock

  0.7TATT Attica Bank SAPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Lavipharm Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lavipharm's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lavipharm or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationDrug Manufacturers - Major, Healthcare (View all Sectors)
Lavipharm SA (LAVI) is traded on Athens Exchange in Greece and employs 5 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lavipharm's market, we take the total number of its shares issued and multiply it by Lavipharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lavipharm SA operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 18.29 M outstanding shares. Lavipharm SA has accumulated about 1.85 M in cash with 3.82 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check Lavipharm Probability Of Bankruptcy
Ownership Allocation
Lavipharm SA maintains a total of 18.29 Million outstanding shares. Lavipharm SA secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 67.47 % of Lavipharm SA outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lavipharm Ownership Details

Lavipharm Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Lavipharm jumping above the current price in 90 days from now is about 34.75%. The Lavipharm SA probability density function shows the probability of Lavipharm stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Lavipharm has a beta of 0.2386. This indicates as returns on the market go up, Lavipharm average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Lavipharm SA will be expected to be much smaller as well. Additionally, lavipharm SA has an alpha of 0.157, implying that it can generate a 0.16 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 0.89HorizonTargetOdds Above 0.89
65.05%90 days
 0.89 
34.75%
Based on a normal probability distribution, the odds of Lavipharm to move above the current price in 90 days from now is about 34.75 (This Lavipharm SA probability density function shows the probability of Lavipharm Stock to fall within a particular range of prices over 90 days) .

Lavipharm SA Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Lavipharm market risk premium is the additional return an investor will receive from holding Lavipharm long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lavipharm. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Lavipharm's alpha and beta are two of the key measurements used to evaluate Lavipharm's performance over the market, the standard measures of volatility play an important role as well.

Lavipharm Stock Against Markets

Picking the right benchmark for Lavipharm stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Lavipharm stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Lavipharm is critical whether you are bullish or bearish towards Lavipharm SA at a given time. Please also check how Lavipharm's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lavipharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze the depth of different equity instruments across global markets
All  Next Launch Module

Lavipharm Corporate Management

Elected by the shareholders, the Lavipharm's board of directors comprises two types of representatives: Lavipharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lavipharm. The board's role is to monitor Lavipharm's management team and ensure that shareholders' interests are well served. Lavipharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lavipharm's outside directors are responsible for providing unbiased perspectives on the board's policies.

How to buy Lavipharm Stock?

Before investing in Lavipharm, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Lavipharm. To buy Lavipharm stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Lavipharm. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Lavipharm stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Lavipharm SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Lavipharm SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Lavipharm SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Lavipharm SA?

The danger of trading Lavipharm SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Lavipharm is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Lavipharm. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Lavipharm SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lavipharm SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Lavipharm Stock analysis

When running Lavipharm's price analysis, check to measure Lavipharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lavipharm is operating at the current time. Most of Lavipharm's value examination focuses on studying past and present price action to predict the probability of Lavipharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lavipharm's price. Additionally, you may evaluate how the addition of Lavipharm to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Correlations
Find global opportunities by holding instruments from different markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Please note, there is a significant difference between Lavipharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lavipharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lavipharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.